Abstract 28
The accessory HIV protein Vpu inhibits a number of cellular pathways 29 that trigger host innate restriction mechanisms. HIV Vpu mediated 30 degradation of Tetherin allows efficient particle release and hampers the 31 activation of the NF-κB pathway thereby limiting the expression of 32 proinflammatory genes. In addition, Vpu reduces cell surface expression of 33 several cellular molecules such as newly synthesized CD4. However the role 34 of HIV Vpu in regulating the type 1 interferon response to viral infection by 35 degradation of the Interferon Regulatory Factor 3 (IRF3) has been subject of 36 conflicting reports. We therefore systematically investigated the expression of 37
IRF3 in primary CD4
+ T cells and macrophages infected with HIV at different 38 time points. In addition, we also tested the ability of Vpu to interfere with 39 innate immune signaling pathways such as the NF-κB and the IRF3 40 pathways. Here we report that HIV Vpu failed to degrade IRF3 in infected 41 primary cells. Moreover, we observed that HIV NL4.3 Vpu had no effect on 42 
HIV Vpu plays a pivotal role in enhancing HIV infection by counteraction of 51
Tetherin. However, Vpu also regulates host response to HIV infection by 52 hampering the type 1 interferon response. The molecular mechanism by 53 which Vpu inhibits the interferon response is still controversial. Here we report 54 that Vpu affects interferon expression by inhibiting NF-κB activity without 55 affecting IRF3 levels or activity. These data suggest that Vpu facilitates HIV 56 infection by regulating NF-κB transcription to levels sufficient for viral 57 transcription while limiting cellular responses to infection. reporter model systems (20) (21) (22) 
CD4
+ T cells and macrophages were fixed and permeabilized using the 178 Cytofix/Cytoperm kit (BD Biosciences), followed by staining with anti-p24 179 antibody KC57 RD1 (1:100 dilution; Coulter Clone) and anti-IRF3 antibody 180
(1:100 dilution Santa Cruz) followed by anti-rabbit Alexa647 (1:500 Life 181 technologies). Gates were set by comparison with isotype-unrelated antibody 182 control MslgG1-RD1 (1:100 dilution; Coulter Clone) and rabbit isotype-183 unrelated antibody control (Invitrogen). In the case of infection with GFP 184 reporter viruses only IRF3 intracellular staining was performed. HIV positive 185 cells were gated on the FITC channel. An average of 5x10 4 cells were 186 collected on a BD™ LSR II flow cytometer and analyzed using FlowJo. 187 HEK 293T were fixed and permeabilized using the Cytofix/Cytoperm kit 188 after 15 minutes treatment with TNFα (10 ng/mL). Cells were stained with 189 anti-IKBα antibody (1:50 dilution; Cell Signaling #9242) followed by anti-rabbit 190 Alexa647 (1:500). Gates were set by comparison with a rabbit isotype- experiments). Replication of both viruses was measured over six days by 264 quantifying infectious particle release in the culture supernatants using the 265
TZM-bl reporter assay (45). Of note, replication of HIV-Δvpu/R5 virus was 266
slightly impaired compared to the WT virus, likely due to the reduced efficacy 267 of the virus to counteract Tetherin ( Fig. 2F) (8, 9) . 268
Since the western blot analysis does not discriminate between infected 269
and not infected cells within a culture, we analyzed the IRF3 levels at the 270 single CD4 + T cell level using flow cytometry analysis. Activated CD4 + T cells, 271 purified from three healthy donors, were infected with replication-competent 272 viruses, HIV NL4.3 nef-IRES-GFP, HIV R7/3 nef-IRES-GFP and HIV LAI. Five 273 days after infection cells were permeabilized and stained for IRF3 (18). The 274 expression of the reporter GFP encoded by NL4.3 and R7/3 allowed us to 275 identify productively infected cells. In the case of LAI, we discriminated 276 infected cells from uninfected by intracellular p24 staining. We observed that 277 intracellular IRF3 expression levels were independent of whether or not the 278 cells were productively infected (Fig. 3A, left and followed the variation of IRF3 levels in infected cells for 7 days. We 284 observed that the levels of IRF3 protein remained constant, similar not only 285 between infected and uninfected cells but also between cells infected with HIV 286 WT and HIV-Δvpu (Fig. 3B) . Of note, the intensity of IRF3 signal was 287 comparable between the infected population and the uninfected (Fig. 3C) . 288
Taken together, these data suggest that the amount of IRF3 protein in 289 the cells is not affected by an ongoing HIV infection. We used three different 290 HIV strains, which all failed to down regulate IRF3 protein levels. 291 292 IRF3 protein levels are comparable in infected and uninfected primary 293
macrophages. 294
We next tested the hypothesis that the effect of Vpu on IRF3 levels 295 could be cell-type specific. We infected primary human macrophages with 296
VSV-G HIV WT-Renilla Luc (VSV-g HIV WT), VSV-G HIV-Δvpu-Renilla Luc 297 (VSV-g HIV-Δvpu). In agreement with our T cell infection experiments, we 298
observed that the levels of IRF3 in macrophages infected with WT or vpu-299 deficient virus and uninfected cells remained comparable (Fig. 4A) . Of note, 300
we provided Vpx containing viral particles (Vpx-VLPs) in trans at the time of 301 infection in order to increase the efficiency of infection (46-48). Levels of IRF3, 302 HIV p24, SAMHD1 and tubulin were determined by western blot analysis five 303 days post infection. The expression of IRF3 remained comparable for all the 304 conditions even when the levels of infection were increased 8-fold by the 305 addition of Vpx ( Fig. 4A and 4B) . independent donors were comparable (Fig. 4E) . 316
To better discriminate variation in IRF3 levels in infected versus 317 uninfected macrophages, we measured intracellular IRF3 expression by flow 318 cytometry. Primary human macrophages from two healthy donors were 319 infected with VSV-G HIV WT in the presence Vpx-VLPs (46-48). Five days 320 post infection, cells were permeabilized and stained for IRF3 and p24 in order 321 to identify productively infected cells (Fig. 5A shows a representative 322 experiment) (49). We observed that the IRF3 levels were comparable 323 between the p24 positive and the p24 negative cell population in both donors 324 (Fig. 5B left panel) . Of note, the percentage of tetherin positive cells is lower 325
in the infected population compared to the uninfected ( were obtained when macrophages were infected with replication competent 332 viruses (Fig. 5D) . 333
It is conceivable the effect of infection on IRF3 levels is only detectable 334 during a particular point of infection. In order to test if IRF3 degradation in 335 infected macrophages was time dependent, primary macrophages infected 336 with VSV-G HIV WT or the Vpu-deleted were monitored for five days. We 337 observed that the levels of IRF3 between uninfected and infected cell 338 populations, remained comparable over the observed period. This was true 339 for both WT and Vpu deleted viruses (Fig. 5E ). We performed a similar 340 analysis in the context of a seven days spreading HIV infection and observed 341 that there were no significant changes in IRF3 levels in p24 pos and p24 neg 342 macrophages (Fig. 5F ). 343
In conclusion, endogenous IRF3 protein expression remained stable in 344 We expressed p55 C1-Luc together with HIV NL4.3 Vpu or GFP alone 358 and induced specific IRF3 dependent transcription by co-transfecting a 359 plasmid coding for TANK-binding kinase 1 (TBK1) (52). We observed that the 360 levels of Luciferase were comparable between cells transfected with Vpu and 361 cells expressing GFP alone suggesting that NL4-3 Vpu does not exert an 362 inhibitory effect on the IRF3 expression under these experimental conditions 363 (Fig. 6A) . 364
The effect of Vpu on the NF-κB pathway was determined using a 365 synthetic NF-κB-Luc reporter plasmid. Activation of NF-κB was achieved by 366 expressing the constitutively active form of IκB kinase β (IKKβca) (53). In line 367 with previous reports, we detected a five fold reduction of the NF-κB promoter 368 activation (p<0.001) (Fig. 6B) (10, 12, 18) . To confirm the reduction of NF-κB 369 activation by Vpu, we co-transfected the c-fos-Luc reporter plasmid together 370 with Vpu or GFP and stimulated the transfected cells 24 hours later with 371
TNFα (20). Activation was measured one day after treatment and showed that 372
Vpu reduced the NF-κB activation by 4-fold (p<0.01) (Fig. 6C) . These results 373 (Fig. 6D) . Taken together, these data 381 indicate that Vpu downmodulates NF-κB activation by stabilizing its inhibitor 382
IκBα but has no effect on IRF3 activation. 383 384 Serines in position 52 and 56 within NL4.3 Vpu are necessary for its 385 inhibitory effect on NF-κB signaling. 386
Vpu downregulates the CD4 receptor from the cell surface and 387 counteracts Tetherin (8, 9, 13). In both cases, Vpu functions as an adapter 388 bridging the ubiquitin-ligase βTrCP with its targets (56-58). This interaction 389 has been proposed to be responsible for the inhibitory effect of Vpu on NF-κB 390 signaling also, with a slightly different mechanism. In the case of CD4 and 391
Tetherin, Vpu links the target proteins to βTrCP inducing their degradation 392 (57, 58). In the case of NF-κB, Vpu binds and sequesters βTrCP at the 393 plasma membrane, hampering its ability to ubiquitinate IKBα upon external 394
stimuli (12, 59). Lack of IKBα ubiquitination blocks its degradation and 395 interferes with NF-κB nuclear translocation (60-62). Interaction between Vpu 396
and βTrCP requires the phosphorylation of Serine 52 and 56 in the 397 cytoplasmic domain of Vpu (12) . 398
To test the hypothesis that interaction of Vpu with βTrCP is important 399 for the inhibitory effect of Vpu on NF-κB dependent transcription, we 400 performed reporter assays in the presence of the NL4.3 Vpu mutant 401 S52N/S56N, which is expressed at the same levels of NL4.3 Vpu WT ( other hand, expression of Vpu-S52N/S56N had no effect on Luciferase 408 expression (Fig. 7B) . (Fig. 7C ). When we analyzed the effect 414 of Vpu-S52N/S56N on NF-κB driven luciferase expression, we observed that 415 this mutant lost its ability to inhibit this pathway while Vpu-WT induced a five 416 fold reduction of NF-κB driven transcription (p<0.001 Fig. 7D ). Taken To explore the extent to which Vpu-induced NF-κB inhibition is strain 423 specific, we performed reporter assays with six different alleles of Vpu. We 424 included Vpu derived from the lab adapted strain NL4.3 together with five Vpu 425 alleles, derived from primary isolates (Fig. 8A) (18) . We co-transfected 426
HEK293T with the different alleles of Vpu and a NF-κB synthetic promoter 427
Firefly luciferase reporter construct. Activation of NF-κB was achieved by 428 expressing IKKβca. The reporter assay shows that all the different Vpu alleles 429 reduce NF-κB activity by 5 to 10 fold (Fig. 8A) . The Vpu proteins were all 430 expressed as shown by western blot analysis (Fig. 8B) . 431
In conclusion, the Vpu alleles from primary isolates tested exert an 432 inhibitory effect on NF-κB signaling pathway similarly to those observed for 433 NL4.3 Vpu (10, 12, 18) . (63, 64) ). We show in this study that 440 NL4.3 Vpu has the ability to down-modulate IFNβ expression in reporter 441 assays without affecting IRF3 levels. Indeed, the levels of IRF3 protein in 442 primary CD4 + T cells and macrophages were not affected by HIV infection. 443
Since activation of the innate immune response is time-dependent, we 444 measured IRF3 expression and HIV infection at different time points in both 445 human primary CD4 + T lymphocytes and macrophages. The proportion of 446
IRF3
+ cells in infected and uninfected populations remained comparable at all 447 the examined time points (Fig. 3B and 5D) . We also analyzed different viral 448 strains, with and without Vpu, but failed to detect IRF3 degradation (Fig. 3A) . 449
While reporter assays using a promoter specific for IRF3 failed to 450 reveal any inhibition of the pathway, we found that Vpu inhibited NF-κB 451 activation downstream of IKKβ activation. HIV Vpu can antagonize NF-κB 452 activation by stabilizing IκBα through its binding with the ubiquitin ligase β-453 TrCP (12). In agreement with this report, mutating the β-TrCP binding motif 454 within NL4.3 Vpu abolished its ability to down-modulate NF-κB pathway (Fig.  455   7D) . 456
Taken together, our data suggest that the lack of IFN pathway 457 induction during HIV infection in primary cells is caused by the inhibition of 458 NF-κB signaling rather than IRF3 degradation. 459
The interplay between HIV Vpu and IRF3 has been subject of several 460 studies from different groups. While our data are in agreement with Hotter and 461 colleagues, they disagree with . immune response in a cell-type specific manner. 500
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